ArticleParasites & vectors2026
The LEF1-LAG3 axis regulates CD4
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundCD4⁺ T cells are pivotal in coordinating anti-malarial immunity, while co-inhibitory receptors such as LAG3 critically regulate their function. However, the phenotype of LAG3⁺CD4⁺ T cells during Plasmodium infection and the upstream molecular mechanisms regulating LAG3 expression remain incompletely elucidated.
methodsWe established a murine model using Plasmodium yoelii NSM (P. yoelii NSM). A multifaceted approach, incorporating single-cell RNA sequencing (scRNA-seq), flow cytometry, magnetic bead-based cell sorting, real-time quantitative polymerase chain reaction (RT-qPCR), dual-luciferase reporter assays, and in vitro cultures with the Wnt agonist CHIR99021, was employed. We characterized splenic CD4⁺ T cell dynamics, the phenotypic and functional profiles of LAG3⁺CD4⁺ T cells, and the transcriptional regulatory relationship between lymphoid enhancer-binding factor 1 (LEF1) and Lag3.
resultsPlasmodium yoelii NSM infection induced significant splenomegaly and remodeling of the splenic CD4⁺ T cell compartment, with increased absolute numbers of CD4⁺ T cells, upregulated activation markers (ICOS, CD69), downregulated naïve marker CD62L, and enhanced secretion of IL-10 and IFN-γ. Both scRNA-seq and flow cytometry confirmed that infection markedly upregulated LAG3 on CD4⁺ T cells. These LAG3⁺CD4⁺ T cells exhibited an activated phenotype, characterized by increased proliferative capacity (Ki67⁺), an increased proportion of the effector phenotype (CD44ʰⁱCD62Lˡᵒ), and concurrent upregulation of multiple co-inhibitory receptors (PD-1, TIM-3, TIGIT). Mechanistically, LEF1 expression was significantly downregulated in CD4⁺ T cells post infection. Dual-luciferase reporter assay demonstrated that LEF1 directly binds to the Lag3 promoter, acting as a transcriptional repressor. Furthermore, treatment with the Wnt agonist CHIR99021, which stabilizes the upstream signaling of LEF1, dose-dependently reduced the frequency of LAG3⁺CD4⁺ T cells.
conclusionsThis study suggests that the LEF1-LAG3 axis is involved in modulating CD4⁺ T cells during P. yoelii NSM infection. LAG3⁺CD4⁺ T cells exhibit an activated phenotype with regulatory potential, which may contribute to balancing anti-parasitic immunity and immunopathology. These findings suggest that modulating LEF1-mediated transcriptional repression of Lag3 offers a promising avenue for fine-tuning anti-malarial immune responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.